GLP-1 is a class of medications that includes several drugs, such as tirzepatide and Ozempic, designed to help with weight loss by mimicking the natural GLP-1 hormone in the body
January 2, 2025: More People File Ozempic Lawsuits Ahead of 2025 As of January 2, 2025, there are 1,331 pending lawsuits against GLP-1 drug manufacturers as part of federal, consolidated litigation
Men taking Ozempic had a 52% higher hair loss rate, while the rate for women taking Ozempic was double that of women in the non-Ozempic group
And there were four patients who went back to weekly frequency because they were regaining weight
PubMed Central, Singla, Rajeev K., et al
I used to wake up with so much anxiety